Company / R&D Expense
HealthStream, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$51.0M
FY2025
5-year range
$29.1M / $51.0M
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#80 of 110
Health Care
What the data says
At $51M, HealthStream, Inc.'s r&d expense ranks #80 of 110 in the Health Care sector. R&D Expense has increased for 6 consecutive years, from $24M in FY2019 to $51M in FY2025.
Based on SEC 10-K filings.
$51M in FY2025 with a 5-year CAGR of +14.7%.
Improved from $46M to $51M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Sector benchmark
#80 of 110 in Health CareTop 73% of 110This company $51.0M Sector average $298.2M
▼
-82.9% below sector average
Key checks
Key Insights
- HealthStream, Inc.'s r&d expense has grown for 6 consecutive years.
- 5-year CAGR of +14.7%, indicating consistent growth.
- In FY2025, r&d expense increased 4.3% year-over-year.
- Ranks #80 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.0M | +4.3% |
| FY2024 | $48.9M | +7.4% |
| FY2023 | $45.5M | +41.0% |
| FY2022 | $32.3M | +11.0% |
| FY2021 | $29.1M | +13.1% |
| FY2020 | $25.7M | +6.6% |
| FY2019 | $24.1M | -0.4% |
| FY2018 | $24.2M | +0.4% |
| FY2017 | $24.1M | +46.7% |
| FY2016 | $16.5M | -32.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026